Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
5
×
immunotherapy
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
novartis
abbvie
amgen
clinical trials
fda
gene therapy
geoffrey porges
gilead sciences
merck
nonalcoholic steatohepatitis
What
roundup
bio
cancer
drug
nash
news
abbvie’s
according
acquisitions
ahead
akcea
albert
annual
approval
ash
barcelona
biggest
biofourmis
biogen’s
biopharmaceutical
biotech
bourla
bucks
cases
celebrate
centers
ceo
chance
cigarettes
clinical
companies
company
conference
control
convo
corner
crispr
day
days
deaths
Language
unset
unknown
Current search:
immunotherapy
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
